GS
BLFS icon

Gagnon Securities’s BioLife Solutions BLFS Stock Holding History

Gagnon Securities’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.1M Sell
535,906
-606
-0.1% -$14.2K 2.92% 15
2026
Q1 		$10.2M Buy
536,512
+2,155
+0.4% +$47.6K 2.36% 16
2025
Q4 		$12.9M Sell
534,357
-1,400
-0.3% -$36.6K 2.63% 15
2025
Q3 		$13.7M Sell
535,757
-4,139
-0.8% -$98.2K 2.74% 11
2025
Q2 		$11.6M Sell
539,896
-1,056
-0.2% -$23.8K 2.36% 16
2025
Q1 		$12.4M Sell
540,952
-26,263
-5% -$692K 2.72% 11
2024
Q4 		$14.7M Sell
567,215
-2,163
-0.4% -$53.8K 2.97% 10
2024
Q3 		$14.3M Sell
569,378
-7,855
-1% -$186K 2.83% 10
2024
Q2 		$12.4M Sell
577,233
-16,159
-3% -$314K 2.79% 10
2024
Q1 		$11M Sell
593,392
-34,087
-5% -$596K 2.61% 12
2023
Q4 		$10.2M Sell
627,479
-5,884
-0.9% -$75.1K 2.45% 17
2023
Q3 		$8.75M Sell
633,363
-4,213
-0.7% -$66.4K 2.19% 19
2023
Q2 		$14.1M Sell
637,576
-12,342
-2% -$260K 2.93% 10
2023
Q1 		$14.1M Buy
649,918
+88,856
+16% +$2M 2.97% 12
2022
Q4 		$10.2M Sell
561,062
-3,301
-0.6% -$68.2K 2.25% 17
2022
Q3 		$12.8M Sell
564,363
-7,316
-1% -$157K 2.82% 9
2022
Q2 		$7.89M Buy
571,679
+192,173
+51% +$2.82M 1.65% 23
2022
Q1 		$8.63M Buy
379,506
+62,537
+20% +$1.65M 1.41% 27
2021
Q4 		$11.8M Sell
316,969
-2,374
-0.7% -$102K 1.77% 26
2021
Q3 		$13.5M Sell
319,343
-63,847
-17% -$3.07M 2.01% 24
2021
Q2 		$17.1M Sell
383,190
-12,690
-3% -$447K 2.42% 14
2021
Q1 		$14.3M Sell
395,880
-10,261
-3% -$406K 2.17% 16
2020
Q4 		$16.2M Sell
406,141
-158
-0% -$5.39K 2.58% 14
2020
Q3 		$11.8M Buy
406,299
+245,223
+152% +$5.3M 2.51% 17
2020
Q2 		$2.63M Buy
+161,076
New +$2.22M 0.64% 32

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Gagnon Securities's BLFS Position: Q2 2026 in Review

Gagnon Securities reduced its BioLife Solutions (BLFS) stake by 0.11% in Q2 2026, selling an estimated $14.2K and leaving 535,906 shares worth $15.1M. The position accounts for 2.92% of the portfolio, ranked #15.

Gagnon Securities first reported a position in BLFS in Q2 2020 and has held it in 25 quarters since. The position peaked at $17.1M in Q2 2021. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • Gagnon Securities held 535,906 shares of BioLife Solutions worth $15.1M as of Q2 2026.
  • Gagnon Securities sold 606 BioLife Solutions shares in Q2 2026, an estimated $14.2K.
  • BioLife Solutions made up 2.92% of Gagnon Securities's portfolio in Q2 2026, its #15 holding.
  • Gagnon Securities first reported a position in BioLife Solutions in Q2 2020 and has held it in 25 quarters since.
  • Gagnon Securities's BioLife Solutions position peaked at $17.1M in Q2 2021.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Gagnon Securities's 13F filing for Q2 2026, filed 5 Aug 2026.